Buy Akorn (AKRX) on Sell-Off, Guggenheim Says

Akorn Announces Recent Executive Appointments

- New EVP Sales and Marketing to Oversee All Akorn Commercial Operations -

- Newly Appointed Controller Strengthens Akorn's Finance Team -

- New EVP Pharmaceutical Operations to Oversee Supply Chain and Plant Operations -

- New EVP Global Quality Compliance to Oversee Akorn's Commitment to Regulatory Compliance -

LAKE FOREST, Ill., April 27, 2015 (GLOBE NEWSWIRE) -- Akorn, Inc. (Nasdaq: AKRX), a leading specialty generic pharmaceutical company, announced the following recent... More

Akorn Appoints Terry Rappuhn to Board of Directors

LAKE FOREST, Ill., April 24, 2015 (GLOBE NEWSWIRE) -- Akorn, Inc. (Nasdaq: AKRX) today announced the appointment of Terry Allison Rappuhn to its Board of Directors and the Board's Audit Committee, effective immediately. In her accomplished career spanning over three decades working with and for public corporations, Ms. Rappuhn has helped rapidly growing companies build infrastructure, processes and teams during periods of transition.

"Terry is a terrific addition to our Board of Directors, and we are extremely pleased to bring her unique talents and financial expertise to Akorn," said Raj Rai, Akorn's Chief... More

Akorn Appoints Terry Rappuhn to Board of Directors

LAKE FOREST, Ill., April 24, 2015 (GLOBE NEWSWIRE) -- Akorn, Inc. (Nasdaq: AKRX) today announced the appointment of Terry Allison Rappuhn to its Board of Directors and the Board's Audit Committee, effective immediately. In her accomplished career spanning over three decades working with and for public corporations, Ms. Rappuhn has helped rapidly growing companies build infrastructure, processes and teams during periods of transition.

"Terry is a terrific addition to our Board of Directors, and we are extremely pleased to bring her unique talents and financial expertise to Akorn," said Raj Rai, Akorn's Chief... More